Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
CD45-targeted antibody- radioimmunoconjugate conjugate
DRUG CLASS:
CD45-targeted antibody- radioimmunoconjugate conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
I-131-apamistamab (1)
I-131-apamistamab (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 mutation
Acute Myelogenous Leukemia
TP53 mutation
Acute Myelogenous Leukemia
I-131-apamistamab
Sensitive: C3 – Early Trials
I-131-apamistamab
Sensitive
:
C3
I-131-apamistamab
Sensitive: C3 – Early Trials
I-131-apamistamab
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login